Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins

Blood Cancer J. 2015 Apr 10;5(4):e300. doi: 10.1038/bcj.2015.27.

¹ 1] Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland [2] Postgraduate School of Molecular Medicine, Warsaw, Poland.
² 1] Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland [2] Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.
³ Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
⁴ Department of Haematology, Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
⁵ 1] Department of Haematology, Institute of Haematology and Transfusion Medicine, Warsaw, Poland [2] Department of Haematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland.
⁶ Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
⁷ Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
⁸ 1] Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland [2] Institute of Physical Chemistry, Polish Academy of Sciences, Department 3, Warsaw, Poland.

No abstract available

Publication types